Get started
Author

Letian Qiao

ORCID: 0009-0006-9533-3597
Observed ORCID: 0009-0006-9533-3597
OpenAlex ID: A5032703279
Comment on: “Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial”
2024 · Letian Qiao, Yuan Liu, et al. · British Journal of Cancer · 2
PDF
Reconsidering residual sleepiness and respiratory events in treated obstructive sleep apnea
2026 · Fan Yuan, Letian Qiao, et al. · European Journal of Internal Medicine · 1
A commentary on ‘Comparison of efficacy and safety between neoadjuvant chemotherapy and neoadjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis’
2024 · Letian Qiao, Yuan Liu, et al. · International Journal of Surgery · 1
A commentary on ‘The efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in people with abdominal and pelvic cancer: a systematic review and meta-analysis based on 23 randomized studies’
2023 · Yuan Liu, Letian Qiao, et al. · International Journal of Surgery · 1
A commentary on ‘Toxicities associated with immune checkpoint inhibitors: a systematic study’
2023 · Yuan Liu, Letian Qiao, et al. · International Journal of Surgery
Meta-analysis of efficacy and safety of ulinuzumab in the treatment of moderate to severe active Crohn's disease
2023 · Yingxia Xie, Letian Qiao, et al.
PDF
Effect and Mechanism of Fructus Ligustri Lucidi in a Mouse Model of Subacute Liver Injury
2023 · Ming Fang, Xiangyang Li, et al. · Current Topics in Nutraceutical Research
Clinical Observation of Bevacizumab Combined with Docetaxel/Cisplatin Used for Patients with Advanced Non-squamous Non-small Cell Lung Cancer
2014 · Letian Qiao · Liaoning Yixueyuan xuebao
Works count: 8
Citation count: 5
H-index: 1
I10-index:
Year
Topic
Type